As the days passed, Cassie’s breathing grew more labored ... doctors again dismissed the severity of her illness after negative tests for COVID-19 and RSV. Once again, no bacterial tests were ...

Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

At 21 months old, Olivia is bright, bubbly, and full of joy. But instead of running around like other toddlers, she’s spent ...

RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...

You’re not imagining it, flu cases are on the rise this season, as vaccination levels decline and COVID-style social ...

Merck is closing in on a $10bn (€8.5bn) deal to acquire respiratory drugmaker Verona Pharma, the Financial Times reported.

In this interview, Professor James J. Collins, founder of the field of Synthetic Biology, discusses his journey to founding ...

As many as 20 people developed a potentially paralysing illness after getting the respiratory syncytial virus (RSV) vaccine.

British regulators issued the alert for two versions of a jab given to millions of pensioners and pregnant women after ...

The UK drug watchdog has issued an alert to the NHS after the RSV jab was linked to a rare condition that needs "urgent ...

OVER 20 people developed a potentially paralysing illness after getting the respiratory syncytial virus (RSV) vaccine. The UK ...